S&P 500   4,557.19 (+0.15%)
DOW   35,448.84 (+0.33%)
QQQ   388.69 (-0.12%)
AAPL   190.05 (+0.14%)
MSFT   381.44 (+0.75%)
META   335.59 (+0.27%)
GOOGL   135.87 (-0.40%)
AMZN   146.43 (-0.88%)
TSLA   234.78 (-0.55%)
NVDA   476.21 (-1.29%)
NIO   7.06 (-1.81%)
BABA   75.58 (-2.52%)
AMD   121.18 (-1.20%)
T   16.11 (-0.62%)
F   10.27 (-0.68%)
MU   74.69 (-3.64%)
CGC   0.53 (-3.82%)
GE   119.40 (-0.48%)
DIS   94.05 (-1.18%)
AMC   6.66 (-2.06%)
PFE   29.86 (-0.93%)
PYPL   56.83 (+0.78%)
XOM   104.23 (+0.26%)
S&P 500   4,557.19 (+0.15%)
DOW   35,448.84 (+0.33%)
QQQ   388.69 (-0.12%)
AAPL   190.05 (+0.14%)
MSFT   381.44 (+0.75%)
META   335.59 (+0.27%)
GOOGL   135.87 (-0.40%)
AMZN   146.43 (-0.88%)
TSLA   234.78 (-0.55%)
NVDA   476.21 (-1.29%)
NIO   7.06 (-1.81%)
BABA   75.58 (-2.52%)
AMD   121.18 (-1.20%)
T   16.11 (-0.62%)
F   10.27 (-0.68%)
MU   74.69 (-3.64%)
CGC   0.53 (-3.82%)
GE   119.40 (-0.48%)
DIS   94.05 (-1.18%)
AMC   6.66 (-2.06%)
PFE   29.86 (-0.93%)
PYPL   56.83 (+0.78%)
XOM   104.23 (+0.26%)
S&P 500   4,557.19 (+0.15%)
DOW   35,448.84 (+0.33%)
QQQ   388.69 (-0.12%)
AAPL   190.05 (+0.14%)
MSFT   381.44 (+0.75%)
META   335.59 (+0.27%)
GOOGL   135.87 (-0.40%)
AMZN   146.43 (-0.88%)
TSLA   234.78 (-0.55%)
NVDA   476.21 (-1.29%)
NIO   7.06 (-1.81%)
BABA   75.58 (-2.52%)
AMD   121.18 (-1.20%)
T   16.11 (-0.62%)
F   10.27 (-0.68%)
MU   74.69 (-3.64%)
CGC   0.53 (-3.82%)
GE   119.40 (-0.48%)
DIS   94.05 (-1.18%)
AMC   6.66 (-2.06%)
PFE   29.86 (-0.93%)
PYPL   56.83 (+0.78%)
XOM   104.23 (+0.26%)
S&P 500   4,557.19 (+0.15%)
DOW   35,448.84 (+0.33%)
QQQ   388.69 (-0.12%)
AAPL   190.05 (+0.14%)
MSFT   381.44 (+0.75%)
META   335.59 (+0.27%)
GOOGL   135.87 (-0.40%)
AMZN   146.43 (-0.88%)
TSLA   234.78 (-0.55%)
NVDA   476.21 (-1.29%)
NIO   7.06 (-1.81%)
BABA   75.58 (-2.52%)
AMD   121.18 (-1.20%)
T   16.11 (-0.62%)
F   10.27 (-0.68%)
MU   74.69 (-3.64%)
CGC   0.53 (-3.82%)
GE   119.40 (-0.48%)
DIS   94.05 (-1.18%)
AMC   6.66 (-2.06%)
PFE   29.86 (-0.93%)
PYPL   56.83 (+0.78%)
XOM   104.23 (+0.26%)

Integral Diagnostics Stock Price, News & Analysis (OTCMKTS:ITGDF)

$2.00
0.00 (0.00%)
(As of 05/12/2023)
Compare
Today's Range
$2.00
$2.00
50-Day Range
$2.00
$2.00
52-Week Range
$2.00
$2.21
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Integral Diagnostics

Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia.

ITGDF Stock Price History

ITGDF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive ITGDF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Diagnostics & Research
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ITGDF
CIK
N/A
Fax
N/A
Employees
2,010
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

  • Dr. Ian Kadish M.B.A. (Age 60)
    MBBCh, CEO, MD & Director
    Comp: $605.75k
  • Mr. Craig White
    Chief Financial Officer
  • Mr. Paul McCrow
    Chief Operating Officer
  • Dr. Jacqueline Milne MBBS
    Executive Director
  • Mr. Julian Gully
    Chief Information Officer
  • Ms. Mica Duncalfe
    Chief People Officer
  • Dr. Lisa Sorger MBBS
    Chief Medical Officer
  • Ms. Kirsty Lally B.Com.
    C.A., Company Secretary














ITGDF Stock Analysis - Frequently Asked Questions

Should I buy or sell Integral Diagnostics stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Integral Diagnostics in the last twelve months. There are currently 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ITGDF shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ITGDF, but not buy additional shares or sell existing shares.
View ITGDF analyst ratings
or view top-rated stocks.

How have ITGDF shares performed in 2023?

Integral Diagnostics' stock was trading at $2.00 at the beginning of the year. Since then, ITGDF stock has increased by 0.0% and is now trading at $2.00.
View the best growth stocks for 2023 here
.

How do I buy shares of Integral Diagnostics?

Shares of ITGDF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:ITGDF) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -